1. Home
  2. IMAB vs TRX Comparison

IMAB vs TRX Comparison

Compare IMAB & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • TRX
  • Stock Information
  • Founded
  • IMAB 2014
  • TRX 1990
  • Country
  • IMAB United States
  • TRX Canada
  • Employees
  • IMAB N/A
  • TRX N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • TRX
  • Sector
  • IMAB Health Care
  • TRX
  • Exchange
  • IMAB Nasdaq
  • TRX Nasdaq
  • Market Cap
  • IMAB 79.9M
  • TRX 89.1M
  • IPO Year
  • IMAB 2020
  • TRX N/A
  • Fundamental
  • Price
  • IMAB $0.96
  • TRX $0.32
  • Analyst Decision
  • IMAB Strong Buy
  • TRX Strong Buy
  • Analyst Count
  • IMAB 3
  • TRX 2
  • Target Price
  • IMAB $8.00
  • TRX $1.63
  • AVG Volume (30 Days)
  • IMAB 286.0K
  • TRX 424.3K
  • Earning Date
  • IMAB 03-13-2025
  • TRX 04-11-2025
  • Dividend Yield
  • IMAB N/A
  • TRX N/A
  • EPS Growth
  • IMAB N/A
  • TRX N/A
  • EPS
  • IMAB N/A
  • TRX 0.01
  • Revenue
  • IMAB $569,464.00
  • TRX $44,282,000.00
  • Revenue This Year
  • IMAB N/A
  • TRX $69.93
  • Revenue Next Year
  • IMAB N/A
  • TRX $21.44
  • P/E Ratio
  • IMAB N/A
  • TRX $59.69
  • Revenue Growth
  • IMAB N/A
  • TRX 16.51
  • 52 Week Low
  • IMAB $0.84
  • TRX $0.28
  • 52 Week High
  • IMAB $2.00
  • TRX $0.49
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 45.33
  • TRX 46.90
  • Support Level
  • IMAB $0.95
  • TRX $0.30
  • Resistance Level
  • IMAB $1.04
  • TRX $0.33
  • Average True Range (ATR)
  • IMAB 0.06
  • TRX 0.01
  • MACD
  • IMAB -0.01
  • TRX 0.00
  • Stochastic Oscillator
  • IMAB 19.88
  • TRX 40.50

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.

Share on Social Networks: